TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).

T R Cottrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.